Endogenous CHTM1 was knockdown by the lentivirus-mediated shRNA approach [5]. The scramble shRNA construct was obtained from Addgene, Inc. (Cambridge, MA, USA). All CHTM1 specific shRNA constructs were obtained from Origene, MD, USA. Three different nucleotide sequences were used to target the human CHTM1: KD-1, 5′-CTTAAGGTAGTGACAGTCC-3′; KD-2, 5′-TCTGTCGAAGACACTCCTC-3′ and KD-3, 5′-TGGAAGTCCTGATATCCAG-3′. Addgene protocol was followed for virus production and infection [5].
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.